J Martin Carroll insider trades
Open-market stock purchases and sales by J Martin Carroll, Director at Esperion Therapeutics, Inc, from SEC Form 4 filings since May 9, 2013.
Track record: 50% of 4 scored buys are up 5% or more since purchase, averaging +24%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 28, 2026 | ESPR Esperion Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ESPR Esperion Therapeutics, Inc: 3 buys, last May 28, 2026
- CTLT Catalent, Inc: other filings, last Dec 18, 2024
- TXMD TherapeuticsMD, Inc: 1 buy, last Aug 10, 2021
- MNKKQ Mallinckrodt plc: 2 sales, last Mar 12, 2021
- MNK Mallinckrodt plc: 3 buys, last May 13, 2020
- ITEK Inotek Pharmaceuticals Corp: 1 buy, last Jun 20, 2017
- DRTX Durata Therapeutics, Inc: other filings, last Nov 17, 2014
- VVUS Vivus Inc: other filings, last Aug 14, 2013